Skip to content

Transobturator Lateral Suspension in Anterior Colporrhaphy

Does Concomitant Transobturator Lateral Suspension Improve Anterior Colporrhaphy Outcomes? A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07144397
Acronym
TLSAC
Enrollment
44
Registered
2025-08-27
Start date
2020-10-09
Completion date
2024-11-23
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Vaginal Wall Prolapse, Pelvic Organ Prolapse

Keywords

anterior colporrhaphy, transobturator lateral suspension, native tissue repair, randomized controlled trial, pelvic organ prolapse

Brief summary

Anterior colporrhaphy (AC) is commonly used for anterior vaginal wall prolapse, but suffers high recurrence rates. This randomized trial assessed whether adding transobturator lateral suspension (TOLS) to AC decreases objective recurrence without compromising patient outcomes. In a cohort of 44 women (POP-Q ≥ 2), AC alone was compared to AC+TOLS over a 1-year follow-up. Results showed significantly lower objective recurrence with the added suspension.

Detailed description

Conducted prospectively at University Medical Centre Maribor (Slovenia), this single-surgeon RCT randomized women with symptomatic anterior vaginal prolapse (POP-Q stage ≥ 2) to receive either standard AC or AC plus bilateral TOLS via non-absorbable suture across the obturator foramen. Primary outcome was objective anatomical recurrence (POP-Q ≥ 2) at 1 year. Secondary outcomes included subjective recurrence, satisfaction (Likert), operative time, postoperative and pelvic sidewall pain, and validated QOL instruments (UIQ-7, CRAIQ-7, POPIQ-7, PFIQ, POPDI-6, UDI-6, PFDI, PISQ).

Interventions

PROCEDURETOLS

Standard AC plus bilateral lateral suspension using non-absorbable sutures passed through the obturator foramen to support lateral vaginal wall.

Sponsors

University Medical Centre Maribor
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women with symptomatic anterior vaginal wall prolapse (POP-Q stage ≥ 2) * Eligible for native tissue repair * Provided written informed consent

Exclusion criteria

* Previous anterior vaginal wall prolapse repair * Predominant apical or posterior compartment defect

Design outcomes

Primary

MeasureTime frameDescription
Objective Recurrence Rate1 year postoperativeAnatomical recurrence defined as POP-Q stage ≥ 2 in anterior compartment

Secondary

MeasureTime frameDescription
Subjective Recurrence Rate1 year postoperativeSubjective recurrence was determined by a positive response to the validated question: Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?
Patient Satisfaction1 year postoperative5-point Likert scale at 1 year
Operative time1 year postoperativeMeasured in minutes during surgery.
Postoperative Pain1 year postoperative.Assessed via VAS at discharge and immediate postoperative period
Pelvic Sidewall Pain1 year postoperative.Assessed at 1 year postoperative clinical examination, by pressing on obutrator membrane. Assesed as present or absent.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026